Drugs for Choroid Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Immunologic Factors |
|
Phase 1 |
|
|
|
2 |
|
Immunoconjugates |
|
Phase 1 |
|
|
|
Interventional clinical trials:
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Collaborative Ocular Melanoma Study (COMS) |
Unknown status |
NCT00000124 |
Phase 3 |
|
2 |
A Phase 1, Open-label, Multicenter Study Evaluating the Safety and Tolerability, Biologic Activity, Pharmacodynamics, and Pharmacokinetics of Single and Repeated Escalating Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma Who Are Planned to Undergo Enucleation or Brachytherapy |
Completed |
NCT02771340 |
Phase 1 |
|
3 |
Characterization of Small Choroidal Tumors Using Functional Optical Coherence Tomography |
Active, not recruiting |
NCT01955915 |
|
|
4 |
Validation of a Molecular Test for Predicting Metastasis in Patients With Uveal Melanoma |
Withdrawn |
NCT00406120 |
|
|
|